Evidence-based protocol for infection control in immediate implant-based breast reconstruction.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22964685.
- Also identified by DOI 10.1097/SAP.0b013e31824a215a.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immediate breast implant reconstruction has among the highest incidence of infections in plastic surgery. A literature search returned key articles that showed a significant decrease in surgical-site infections by performing nasal swab evaluation to treat methicillin-sensitive and methicillin-resistant Staphylococcus aureus before surgery with mupirocin nasal ointment and 5 days of chlorhexidine scrub to the surgical area. Additional Level 1 data supported the use of chlorhexidine-alcohol over povidone-iodine solutions for skin preparation. Intraoperative data on breast pocket irrigation showed the benefits of povidone-iodine as well as a triple antibiotic solution. Nasal swabs from 120 patients showed no methicillin-resistant S. aureus but did identify 10 patients with methicillin-sensitive S. aureus, 1 with streptococcus, and 3 with gram-negative rods, which changed perioperative antibiotic management. On the basis of the previously mentioned data, an evidence-based protocol for infection control was developed to potentially decrease infection rates. Further cost and efficacy data are warranted.
Medical subject headings
- Anti-Bacterial Agents
- Antibiotic Prophylaxis
- Breast Implantation
- Perioperative Care
- Staphylococcal Infections
- Staphylococcus aureus
- Surgical Wound Infection